156 related articles for article (PubMed ID: 1554517)
21. Association of expression between N-myc gene and major histocompatibility complex class I gene in surgically resected human neuroblastoma.
Sugio K; Nakagawara A; Sasazuki T
Cancer; 1991 Mar; 67(5):1384-8. PubMed ID: 1991301
[TBL] [Abstract][Full Text] [Related]
22. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
23. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
24. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma.
Suita S; Zaizen Y; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Utsumi J; Takahashi H; Yokoyama J; Nishihira H
J Pediatr Surg; 1994 Jun; 29(6):746-50. PubMed ID: 8078011
[TBL] [Abstract][Full Text] [Related]
25. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
[TBL] [Abstract][Full Text] [Related]
26. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal localization of amplified N-myc in neuroblastoma cells using a biotinylated probe.
Rudduck C; Lukeis RE; McRobert TL; Chow CW; Garson OM
Cancer Genet Cytogenet; 1992 Jan; 58(1):55-9. PubMed ID: 1728951
[TBL] [Abstract][Full Text] [Related]
28. Neuroblastoma with focal MYCN amplification and bone marrow infiltration: a staging and treatment dilemma.
Kerbl R; Ambros IM; Ambros PF; Lackner H; Dornbusch HJ; Urban CE
Med Pediatr Oncol; 2002 Feb; 38(2):109-11. PubMed ID: 11813175
[No Abstract] [Full Text] [Related]
29. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
[TBL] [Abstract][Full Text] [Related]
30. N-myc oncogene amplification in a patient with IV-S neuroblastoma.
Tonini GP; Verdona G; De Bernardi B; Sansone R; Massimo L; Cornaglia-Ferraris P
Am J Pediatr Hematol Oncol; 1987; 9(1):8-10. PubMed ID: 3592119
[TBL] [Abstract][Full Text] [Related]
31. N-myc gene amplification and other prognosis-associated factors in neuroblastoma.
Hiyama E; Yokoyama T; Ichikawa T; Ishii T; Hiyama K
J Pediatr Surg; 1990 Oct; 25(10):1095-9. PubMed ID: 2262866
[TBL] [Abstract][Full Text] [Related]
32. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
[TBL] [Abstract][Full Text] [Related]
33. Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H; Delattre O; Hartmann O; Combaret V; Michon J; Bénard J; Peyroulet MC; Plantaz D; Coze C; Chastagner P; Baranzelli MC; Frappaz D; Lemerle J; Sommelet D
Eur J Cancer; 1997 Oct; 33(12):1917-22. PubMed ID: 9516824
[TBL] [Abstract][Full Text] [Related]
34. A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases.
Tanaka T; Slamon DJ; Shimada H; Shimoda H; Fujisawa T; Ida N; Seeger RC
Cancer; 1991 Sep; 68(6):1296-302. PubMed ID: 1873783
[TBL] [Abstract][Full Text] [Related]
35. Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification.
Chen B; Jhanwar SC; Ladanyi M
Diagn Mol Pathol; 2001 Jun; 10(2):100-4. PubMed ID: 11385318
[TBL] [Abstract][Full Text] [Related]
36. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
37. N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis.
Hedborg F; Lindgren PG; Johansson I; Kogner P; Samuelsson BO; Bekassy AN; Olsen L; Kreuger A; Påhlman S
Med Pediatr Oncol; 1992; 20(4):292-300. PubMed ID: 1608350
[TBL] [Abstract][Full Text] [Related]
38. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.
Taylor SR; Locker J
Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684
[TBL] [Abstract][Full Text] [Related]
39. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the risk factor for the poor prognosis of localized neuroblastoma after the surgical.
Zhou K; Li XL; Pan J; Xu JZ; Wang J
Medicine (Baltimore); 2018 Oct; 97(40):e12718. PubMed ID: 30290678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
